Law Firm Seeks Medpace Investors to Lead Securities Class Action

Overview

• The Law Offices of Frank R. Cruz says Medpace shareholders who lost money can ask the court to be lead plaintiff, with a June 8, 2026 deadline.
• According to the firm, the complaint targets statements made from April 22, 2025 through February 9, 2026.
• The filing claims Medpace oversold a fourth-quarter 2025 book-to-bill target of 1.15 and downplayed how project cancellations would affect that metric.
• It also alleges the company brushed off concerns about a narrow pre-backlog and portrayed recent growth as broad-based rather than concentrated in a few metabolic studies.
• Book-to-bill compares new contract wins to work billed and is used as a signal for future revenue, and the firm notes investors may choose their own counsel or take no action and that the release may be attorney advertising.